MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    The utility of electrophysiological tests in the differentiation of upper limb tremor in young-onset patients

    P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To explore the diagnostic utility of neurophysiologic tests in young-onset patients who present primarily with upper limb action tremor. Background: In young-onset patients, isolated…
  • 2018 International Congress

    Case series of Holmes tremor at the Clinical Hospital of State University of Campinas

    F. de Moraes, F. de Paula, S. Filho, P. de Azevedo, L. Piovesana (Campinas, Brazil)

    Objective: To describe a case series of Holmes tremor (HT) from Movement Disorders Outpatient Clinic at the Clinical Hospital of State University of Campinas, from…
  • 2018 International Congress

    Voluntary suppression of Parkinson’s tremor

    R. Blakemore, M. MacAskill, D. Myall, T. Anderson (Christchurch, New Zealand)

    Objective: To provide the first detailed systematic investigation of the phenomenon of voluntary tremor suppression in Parkinson’s disease (PD). Background: We have observed in the…
  • 2018 International Congress

    Phenotypic variability of essential tremor based on the age at onset

    S. Prasad, A. Lenka, K. Jhunjhunwala, K. Bhalsing, P. Pal (Bengaluru, India)

    Objective: To explore the distribution of the AAO of essential tremor based on mathematical modeling and ascertain differences in the clinical features of subgroups. Background:…
  • 2018 International Congress

    Role of Sex on Cholinergic Activity and Attention in Parkinson’s disease

    D. Martini, R. Morris, T. Madhyastha, T. Grabowski, J. Quinn, F. Horak (Portland, OR, USA)

    Objective: To determine whether cholinergic activity related to attention differs in males versus females in people with Parkinson’s disease (PwPD). Background: Although cholinergic activity is…
  • 2018 International Congress

    The effects of sensory reward cues on risky decision making in Parkinson’s disease

    M. Cherkasova, P. Surathi, S. Yeung, AJ. Stoessl, M. McKeown, S. Appel-Cresswell, C. Winstanley, J. Barton (Vancouver, BC, Canada)

    Objective: To evaluate the effects of sensory reward cues on risky decision making in unmedicated and medicated Parkinson’s disease (PD). Background: Cue reactivity may play…
  • 2018 International Congress

    Clinical predictors of screen-defined dementia in early Parkinson’s

    F. Baig, M. Lawton, M. Rolinski, C. Ruffmann, T. Barber, J. Klein, C. Lo, Y. Ben-Shlomo, M. Hu (Oxford, United Kingdom)

    Objective: Predicting early dementia in Parkinson’s disease (PD) has important implications for individual prognosis, designing clinical trials and targeting novel treatments, but there remains a…
  • 2018 International Congress

    Exploring the relationship between motor impairment, vascular burden and cognition in Parkinson’s disease

    T. Stojkovic, E. Stefanova, I. Soldatovic, V. Markovic, I. Stankovic, F. Agosta, I. Petrovic, S. Galantucci, M. Filippi, V. Kostic (Belgrade, Serbia)

    Objective: To determine frequency and type of cognitive disorders in cross-sectional analysis of a Parkinson’s disease (PD) cohort, and explore its relations to motor symptoms,…
  • 2018 International Congress

    FDG-PET and metabolomics in PD-associated GBA variants

    A. Greuel, JP. Trezzi, E. Glaab, C. Jäger, Z. Hodak, K. Lohmann, C. Klein, L. Timmermann, A. Drzezga, M. Tittgemeyer, Y. Ma, N. Diederich, C. Eggers (Marburg, Germany)

    Objective: To assess the clinical, cognitive, metabolic, and imaging phenotypes of PD patients carrying the variants p.E365K and p.T408M in the GBA gene (NM_000157.3). Background:…
  • 2018 International Congress

    MANF improves the MPP+/MPTP-induced Parkinson’s disease via improvement of mitochondrial function and inhibition of oxidative stress

    Y. Liu, J. zhang, Q. Cai, H. Sun, L. Jin (Shanghai, China)

    Objective: This study aimed to investigate the therapeutic effect of mesencephalic astrocyte-derived neurotrophic factor (MANF) on the MPTP/MPP+-induced model of Parkinson's disease (PD) and the…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley